Published in Endocrinology on August 01, 1986
Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. J Clin Invest (2008) 2.77
Actions and interactions of alcohol and insulin-like growth factor-1 on female pubertal development. Alcohol Clin Exp Res (2009) 0.84
Alcohol alters insulin-like growth factor-1-induced transforming growth factor β1 synthesis in the medial basal hypothalamus of the prepubertal female rat. Alcohol Clin Exp Res (2014) 0.79
Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis. Br J Cancer (1992) 0.78
Integrating metabolism and longevity through insulin and IGF1 signaling. Endocrinol Metab Clin North Am (2012) 0.78
Central nervous system control of food intake. Nature (2000) 15.85
Central nervous system control of food intake and body weight. Nature (2006) 11.89
The effect of epinephrine on immunoreactive insulin levels in man. J Clin Invest (1966) 4.92
Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature (1979) 4.08
Identification of targets of leptin action in rat hypothalamus. J Clin Invest (1996) 3.49
A receptor mechanism for the inhibition of insulin release by epinephrine in man. J Clin Invest (1967) 3.48
Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med (1996) 3.20
Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci (1998) 3.17
The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest (1967) 2.87
Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest (1984) 2.85
Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes (1996) 2.83
Signals that regulate food intake and energy homeostasis. Science (1998) 2.70
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology (1998) 2.61
Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res (2003) 2.57
Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab (1976) 2.39
Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes (1997) 2.32
A new LexA-based genetic system for monitoring and analyzing protein heterodimerization in Escherichia coli. Mol Gen Genet (1998) 2.25
Neural control of the endocrine pancreas. Physiol Rev (1974) 2.21
Beta adrenergic stimulation of insulin release in man. Diabetes (1967) 2.14
Insulin secretion in diabetes mellitus. Am J Med (1981) 2.05
Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev (1992) 2.03
Melanocortin receptors in leptin effects. Nature (1997) 2.01
Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes (1990) 2.00
Diabetic lipemia. A form of acquired fat-induced lipemia. N Engl J Med (1967) 1.87
Hypertriglyceridemia. A metabolic consequence of chronic renal failure. N Engl J Med (1968) 1.85
Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nat Med (1995) 1.82
Sympathetic regulation of insulin secretion. Its relation to diabetes mellitus. Arch Intern Med (1969) 1.81
Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A (1996) 1.80
Inhibition of insulin release by norepinephrine in man. Science (1966) 1.78
Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes (1982) 1.69
Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest (1993) 1.67
Insulin responses to glucose: evidence for a two pool system in man. J Clin Invest (1969) 1.66
Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology (1992) 1.65
Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res (1999) 1.64
Obesity, diabetes and the central nervous system. Diabetologia (1998) 1.62
The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes. Diabetes (1982) 1.59
Human insulin secretion: as integrated approach. Annu Rev Med (1970) 1.55
Food intake and the regulation of body weight. Annu Rev Psychol (2000) 1.55
The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J Clin Invest (1973) 1.53
AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem (2001) 1.51
Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia (1986) 1.49
Relationship between intravenous glucose loads, insulin responses and glucose disappearance rate. J Clin Endocrinol Metab (1971) 1.48
Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care (1984) 1.48
Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr (2001) 1.45
MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. Proc Natl Acad Sci U S A (1997) 1.44
Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes (1995) 1.44
Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. J Clin Endocrinol Metab (1985) 1.43
Effect of glucagon on serum insulin, plasma glucose and free fatty acids in man. Metabolism (1966) 1.41
Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1998) 1.38
Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest (1973) 1.38
Influence of hydrogen peroxide or alcoholic sodium hydroxide on the immunocytochemical detection of growth hormone and prolactin after osmium fixation. J Histochem Cytochem (1979) 1.35
Glucagon release induced by pancreatic nerve stimulation in the dog. J Clin Invest (1973) 1.35
Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia (1987) 1.34
Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology (1990) 1.32
Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol (1990) 1.31
Comparison of double- and single-isotope enzymatic derivative methods for measuring catecholamines in human plasma. Clin Chem (1978) 1.30
The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes (1986) 1.30
Adrenergic modulation of basal insulin secretion in man. Diabetes (1973) 1.29
Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol (1984) 1.29
Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes (1996) 1.29
Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system. Fed Proc (1973) 1.28
Neural regulation of insulin secretion in the dog. J Clin Invest (1973) 1.28
Effect of a fat free, high carbohydrate diet on diabetic subjects with fasting hyperglycemia. Diabetes (1974) 1.27
Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and co-localization with neuropeptide Y mRNA in the arcuate nucleus. J Histochem Cytochem (1999) 1.26
Glucose disposal is not proportional to plasma glucose level in man. Diabetes (1981) 1.26
Insulin: its relationship to the central nervous system and to the control of food intake and body weight. Am J Clin Nutr (1985) 1.25
Improved glucose tolerance with high carbohydrate feeding in mild diabetes. N Engl J Med (1971) 1.25
Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology (1998) 1.24
Insulin in the brain. Annu Rev Physiol (1987) 1.23
Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm Metab Res (1996) 1.23
Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab (1987) 1.22
Acute and steady-state insulin responses to glucose in nonobese diabetic subjects. J Clin Invest (1972) 1.22
Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes (1994) 1.21
Mechanism of plasma catecholamine increases during surgical stress in man. J Clin Endocrinol Metab (1977) 1.20
Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes (1985) 1.19
A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest (1976) 1.19
Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes (1988) 1.18
Glycosylated hemoglobin in normal subjects and subjects with maturity-onset diabetes. Evidence for a saturable system in man. Diabetes (1978) 1.17
Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. J Clin Endocrinol Metab (1979) 1.15
Cardiovascular and metabolic responses to exercise in a patient with McArdle's syndrome. N Engl J Med (1966) 1.13
Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia). J Clin Invest (1970) 1.13
Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J Clin Invest (1991) 1.12
Quantitative evaluation of sympathetic and parasympathetic control of iris function. Diabetes Care (1984) 1.11
Relationship between plasma and cerebrospinal fluid insulin levels of dogs. Am J Physiol (1977) 1.10
Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1990) 1.09
The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J Clin Invest (1996) 1.09
The evaluation of insulin as a metabolic signal influencing behavior via the brain. Neurosci Biobehav Rev (1996) 1.09
Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes (1989) 1.09
Immunocytochemistry with osmium-fixed tissue. I. Light microscopic localization of growth hormone and prolactin with the unlabeled antibody-enzyme method. J Histochem Cytochem (1979) 1.08